News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,453 Results
Type
Article (86481)
Company Profile (702)
Press Release (759270)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232676)
Career Advice (4127)
Deals (39719)
Drug Delivery (129)
Drug Development (90982)
Employer Resources (198)
FDA (18106)
Job Trends (17334)
News (396451)
Policy (39746)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56833)
ALS (99)
Alzheimer's disease (1503)
Antibody-drug conjugate (ADC) (157)
Approvals (18068)
Artificial intelligence (329)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (304)
Cancer (2452)
Cardiovascular disease (206)
Career advice (3534)
Career pathing (34)
CAR-T (174)
Cell therapy (494)
Cervical cancer (21)
Clinical research (73409)
Collaboration (916)
Company closure (1)
Compensation (567)
Complete response letters (30)
COVID-19 (2868)
CRISPR (48)
C-suite (266)
Cystic fibrosis (107)
Data (2284)
Decentralized trials (2)
Denatured (45)
Depression (56)
Diabetes (299)
Diagnostics (6922)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (128)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (96697)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130055)
Executive appointments (781)
FDA (19454)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (819)
Gene editing (120)
Generative AI (35)
Gene therapy (359)
GLP-1 (856)
Government (5160)
Grass and pollen (6)
Guidances (75)
Healthcare (20886)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (148)
Indications (30)
Infectious disease (3029)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (101)
Interviews (812)
IPO (17817)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (559)
Leadership (24)
Legal (10113)
Liver cancer (82)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (65)
Manufacturing (354)
MASH (76)
Medical device (14639)
Medtech (14644)
Mergers & acquisitions (22445)
Metabolic disorders (794)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (114)
Neuropsychiatric disorders (34)
Neuroscience (2110)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (40)
Obesity (427)
Opinion (275)
Ovarian cancer (79)
Pain (99)
Pancreatic cancer (88)
Parkinson's disease (161)
Partnered (24)
Patents (251)
Patient recruitment (116)
Peanut (51)
People (65306)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22656)
Phase II (31869)
Phase III (24016)
Pipeline (1265)
Policy (173)
Postmarket research (3552)
Preclinical (10223)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (430)
Real estate (7392)
Recruiting (75)
Regulatory (26802)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (91)
Service/supplier (30)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4291)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (47)
The Weekly (82)
Vaccines (815)
Venture capitalists (44)
Weight loss (305)
Women's health (40)
Worklife (20)
Date
Today (147)
Last 7 days (997)
Last 30 days (2807)
Last 365 days (35810)
2025 (11992)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (50135)
Australia (8831)
California (6482)
Canada (2075)
China (564)
Colorado (284)
Connecticut (303)
Delaware (160)
Europe (114995)
Florida (947)
Georgia (221)
Hawaii (1)
Idaho (64)
Illinois (633)
India (31)
Indiana (337)
Iowa (12)
Japan (171)
Kansas (111)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (973)
Massachusetts (4967)
Michigan (249)
Minnesota (423)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (70)
New Jersey (1834)
New Mexico (31)
New York (1840)
North Carolina (1134)
North Dakota (9)
Northern California (2768)
Ohio (220)
Oklahoma (15)
Oregon (48)
Pennsylvania (1426)
Puerto Rico (13)
Rhode Island (36)
South America (1652)
South Carolina (24)
South Dakota (1)
Southern California (2403)
Tennessee (105)
Texas (973)
United States (24906)
Utah (194)
Virginia (172)
Washington D.C. (71)
Washington State (607)
West Virginia (3)
Wisconsin (70)
There are 846,453 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025
May 5, 2025
·
4 min read
Press Releases
Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
May 5, 2025
·
7 min read
Press Releases
Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress
May 5, 2025
·
8 min read
Press Releases
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
May 5, 2025
·
2 min read
Press Releases
BioInvent to Participate in Upcoming Investor Conferences
May 5, 2025
·
2 min read
Press Releases
Micro Medical Solutions Appoints George Quinoy as Chief Commercial Officer to Accelerate Global Growth
May 5, 2025
·
2 min read
Press Releases
INTREPID Alliance Releases New Report Highlighting Urgent Gaps in Antiviral Preparedness
May 5, 2025
·
6 min read
Press Releases
Psomagen Selected as Key Service Provider, Will Utilize Ultima Genomics’ UG 100™ Sequencer to Accelerate Chan Zuckerberg Initiative’s Billion Cells Project
May 5, 2025
·
4 min read
Press Releases
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab
May 5, 2025
·
8 min read
Press Releases
Vanda Announces Bysanti™ NDA Filing; FDA Decision Expected in Early 2026
May 5, 2025
·
5 min read
1 of 84,646
Next
